Merck Serono delivers strong earnings growth on back of cost-cutting program

New Stories

• Patients and clinicians defend MS treatment choice during review stakeholder meeting

  November 5, 2026 - - Latest News

• Vaccines dominate public health spending but prevention investment slips

  November 5, 2026 - - Latest News

• Increased accountability can be the only response to expanding authority

  November 5, 2026 - - Latest News

• Sydney summit program focused on the reshaping power of AI

  November 4, 2026 - - Latest News

• Is the reluctance to revisit term limits because they are such an obvious change?

  November 4, 2026 - - Latest News

• Does new report suggest that patient voice reforms are stalling?

  November 4, 2026 - - Latest News

• Medicines industry faces tough PBS talks, but will it be the most challenging ever?

  November 3, 2026 - - Latest News